PATENT CLAIM ANALYSIS

Application Number: 16436143
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-09
Patent Classification: ["424", "489000"]

Abstract:
It is the object of the present invention a pharmaceutical composition for use in humans or animals containing N-palmitoylethanolamide for the control of the inflammatory and/or neuropathic pain of various origin. In particular, the present invention relates to a pharmaceutical composition comprising palmitoylethanolamide (PEA and L-acetylcarnitine (LAC), optionally with in addition an antioxidant compound such as a polyphenol, alpha-lipoic acid, and L-acetylcysteine.

Claim (Index 3):
The pharmaceutical composition according to  claim 1 , wherein said L-acetylcarnitine is in finely pulverized form.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 100.0
- Lexical Diversity: 1.39216
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15603566', '14711112', '13925435', '14323673', '14378185']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7241363090542523
- 35 USC 102 Novelty (BERT): 0.5292463743873123
- Combined Prediction Score: 0.7046473155875583
- Mean Citation Score: 217.830082
- Max Citation Score: 327.0214200000001
- Similarity Product: 205.97226807627445

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test